Showing results (531-540 of 579) with videos related to

Sort By:
Pageof 58
Cancer|December 21, 2022
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in ChinaYan Gao, Yizhen Liu, Yafei Wang, et al.
Journal of Natural Products|March 18, 2022
A Natural Plant Ingredient, Menthone, Regulates T Cell Subtypes and Lowers Pro-inflammatory Cytokines of Rheumatoid ArthritisXiangjie Chen, Qiuyu Wu, Zheng Gong, et al.
American Journal of Hematology|May 30, 2025
Challenging the Adverse Label: Diverse Outcomes of ELN 2022 Adverse Cytogenetic Subgroups in Acute Myeloid Leukemia Patients Allografted in First Remission: From EBMT ALWPAli Bazarbachi, Jacques-Emmanuel Galimard, Iman Abou Dalle, et al.
British Journal of Haematology|February 12, 2024
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO studyMatteo Sarocchi, Junmin Li, Xiao Li, et al.
Cancer Letters|September 27, 2024
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 updateYu Wang, Ying-Jun Chang, Jing Chen, et al.
Blood|June 9, 2023
Safety and efficacy of an anti-human APC antibody for prophylaxis of congenital factor deficiencies in preclinical modelsMiao Jiang, Fei Yang, Yizhi Jiang, et al.
Leukemia|February 5, 2021
Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMTJordi Esteve, Sebastian Giebel, Myriam Labopin, et al.
Blood Advances|April 7, 2022
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein CMiao Jiang, Fei Yang, Yizhi Jiang, et al.
Haematologica|November 27, 2025
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter studyMingkai Shu, Wenjing Ding, Linlin Wang, et al.
Annals of Hematology|November 20, 2025
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter studyYuqing Tu, Lingyi Yang, Yaxin Cheng, et al.
Pageof 58